🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
PTC
$PTCT
🔒 US EquitiesPTC Therapeutics, Inc.
AVG HISTORICAL GAP
-1.39%
MAX GAP RECORD
-19.16%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $PTCT
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$PTCT
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 29, 2026 Earnings Release 2026-10-29 (AFTER CLOSE (16:00)) |
+0.45%
|
| Jul 30, 2026 Earnings Release 2026-07-30 (AFTER CLOSE) |
-6.09%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
+14.86%
|
| Feb 19, 2026 Earnings Release 2026-02-19 (AFTER CLOSE) |
-2.07%
|
| Nov 04, 2025 Earnings Release 2025-11-04 (AFTER CLOSE) |
+3.37%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE) |
-10.64%
|
| May 06, 2025 Earnings Release 2025-05-06 (AFTER CLOSE) |
+8.87%
|
| Feb 27, 2025 Earnings Release 2025-02-27 (AFTER CLOSE) |
-10.12%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
6.8%
Bullish Gaps (7)
Bearish Gaps (8)
Neutral / Flat (1)
📖 Intelligence Summary
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children and adults living with rare disorders in the United States and internationally. The company provides Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC)…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗